Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > What have we got here?
View:
Post by Azzak34 on Jun 20, 2023 11:46am

What have we got here?

https://www.mirror.co.uk/news/uk-news/bowel-cancer-treatment-breakthrough-scientists-30275322?int_source=amp_continue_reading&int_medium=amp&int_campaign=continue_reading_button#amp-readmore-target
Comment by 13X2413 on Jun 20, 2023 11:51am
What we've got here is a company that gain any traction. Too many sellers for a company that's supposed to have something.  Would like to jump ship like others, but I'm down too much now. 
Comment by 13X2413 on Jun 20, 2023 11:55am
Should read can't gain. 
Comment by JohnnyYeg on Jun 20, 2023 1:52pm
And exactly how many "sellers" of the 64,092,904 outstanding shares are selling? And conversely, how many are holding pat? Might give you some idea about the sentiment held by shareholders towards the company and future of Pelareorep.
Comment by Noteable on Jun 20, 2023 12:03pm
ONCY's pelareorep activates the interferon (IFN) signalling pathway which stimulates the innate and adaptive immune system where  gamma-delta (γδ) T cells, play a critical role in filling the gap needed for adaptive immune cells maturation, linking the innate and adaptive immunity together. The AWARE-1 study results presented at SABC 2022 on December 07, 2022 demonstrated ...more  
Comment by Noteable on Jun 20, 2023 12:04pm
“Pelareorep primes the tumor for checkpoint inhibition therapy by activating the interferon-gamma signaling pathway and tumor inflammation signature in early breast cancer patients - results of the AWARE-1 trial” Loghmani, Houra et al, Previously presented at the 2022 San Antonio Breast Cancer Symposium®; December 6-10, 2022 https://www.oncolyticsbiotech.com/technology/posters ...more  
Comment by Noteable on Jun 20, 2023 12:15pm
Loghmani's findings from the AWARE-1 clinical trial suggests that pelareorep works synergistically with Roche's PD-(1) immune checkpoint inhibitor Tecentiriq.
Comment by Noteable on Jun 20, 2023 12:18pm
March 31, 2022 /CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced the successful completion of the three-patient safety run-in for the third-line metastatic colorectal cancer (mCRC) cohort of the phase 1/2 GOBLET study, following an independent review by the study's Data Safety Monitoring Board (DSMB).  https://www.oncolyticsbiotech.com/press ...more  
Comment by 13X2413 on Jun 20, 2023 12:50pm
Noteable.....love all your positivity. The dated info has to stop. We need fresh info. No one cares about old news which has been factored into the current share price.  What scares me is that the big players don't seem impressed about the previous news. If they were as hopeful as you, we wouldn't be floundering at this level.  We need news, not pipe dreams about buyouts!
Comment by Noteable on Jun 20, 2023 12:51pm
13X2413 go back from where you came.
Comment by Noteable on Jun 20, 2023 12:54pm
13X2413 first appeared on this messge board on May 26, 2023 and has posted junk ever since.
Comment by westcoast1000 on Jun 20, 2023 3:26pm
Yes and our panc results of last fall indicate that synergy as well, as I understand it. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities